TB Research

In vitro growth inhibition and bactericidal activity of spathulenol against drug-resistant clinical isolates of Mycobacterium tuberculosis

Ángel de Jesús Dzul-Beh, Karlina García‐Sosa, Andrés Humberto Uc‐Cachón, Jorge Bórquez, Luis Loyola, Hugo Barrios-García, Luis M. Peña-Rodrı́guez, Gloria María Molina‐Salinas

Revista Brasileira de Farmacognosia · 2019-07

Abstract

Spathulenol was isolated from an extract of Azorella compacta Phil., Apiaceae, by various chromatographic method; identification of the chemical structure was confirmed by comparing its spectroscopic data with those reported in the literature. The anti-Mycobacterium tuberculosis activity of spathulenol was evaluated on MDR, pre-XDR, and XDR clinical isolates of M. tuberculosis, as well as on the reference susceptible strain H37Rv and its cytotoxic activity was evaluated on the Vero Cell Line. The anti-M. tuberculosis activity of spathulenol was twice as potent against the MDR, pre-XDR, and XDR clinical isolates (6.25 µg/ml) than on the susceptible H37Rv strain (12.5 µg/ml). Additionally, the anti-M. tuberculosis activity shown by spathulenol was established as bactericidal on drug-resistant and susceptible strains of M. tuberculosis. Finally, cytotoxic activity on the Vero cell line (CC50 = 95.7 µg/ml) indicated that spathulenol is a selective anti-M. tuberculosis compound, with a selective index of 15.31 against drug-resistant clinical isolates of M. tuberculosis.

MeSH terms

  • Mycobacterium tuberculosis
  • Microbiology
  • Tuberculosis
  • Vero cell
  • Apiaceae
  • Biology
  • Strain (injury)
  • In vitro
  • Chemistry
  • Virology